196 related articles for article (PubMed ID: 34017066)
1. AKR1C1 connects autophagy and oxidative stress by interacting with SQSTM1 in a catalytic-independent manner.
Chang LL; Li YK; Zhao CX; Zeng CM; Ge FJ; Du JM; Zhang WZ; Lu PH; He QJ; Zhu H; Yang B
Acta Pharmacol Sin; 2022 Mar; 43(3):703-711. PubMed ID: 34017066
[TBL] [Abstract][Full Text] [Related]
2. AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.
Zhu H; Chang LL; Yan FJ; Hu Y; Zeng CM; Zhou TY; Yuan T; Ying MD; Cao J; He QJ; Yang B
Theranostics; 2018; 8(3):676-692. PubMed ID: 29344298
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the EGFR-SQSTM1 interaction by a stapled peptide suppresses lung cancer via activating autophagy and inhibiting EGFR signaling.
Yu JJ; Zhou DD; Cui B; Zhang C; Tan FW; Chang S; Li K; Lv XX; Zhang XW; Shang S; Xiang YJ; Chen F; Yu JM; Liu SS; Wang F; Hu ZW; Hua F
Cancer Lett; 2020 Apr; 474():23-35. PubMed ID: 31931029
[TBL] [Abstract][Full Text] [Related]
4. ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway.
Deng Z; Lim J; Wang Q; Purtell K; Wu S; Palomo GM; Tan H; Manfredi G; Zhao Y; Peng J; Hu B; Chen S; Yue Z
Autophagy; 2020 May; 16(5):917-931. PubMed ID: 31362587
[TBL] [Abstract][Full Text] [Related]
5. Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation.
Zhang XW; Zhou JC; Peng D; Hua F; Li K; Yu JJ; Lv XX; Cui B; Liu SS; Yu JM; Wang F; Jin CC; Yang ZN; Zhao CX; Hou XY; Huang B; Hu ZW
Autophagy; 2020 May; 16(5):782-796. PubMed ID: 31286822
[TBL] [Abstract][Full Text] [Related]
6. p62/Sequestosome 1 regulates transforming growth factor beta signaling and epithelial to mesenchymal transition in A549 cells.
Trelford CB; Ng E; Campbell CI; Di Guglielmo GM
Cell Signal; 2021 Sep; 85():110040. PubMed ID: 34000385
[TBL] [Abstract][Full Text] [Related]
7. m
Liang D; Lin WJ; Ren M; Qiu J; Yang C; Wang X; Li N; Zeng T; Sun K; You L; Yan L; Wang W
Autophagy; 2022 Jun; 18(6):1318-1337. PubMed ID: 34657574
[TBL] [Abstract][Full Text] [Related]
8. Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P.
Liao CC; Ho MY; Liang SM; Liang CM
Autophagy; 2018; 14(12):2065-2082. PubMed ID: 30081720
[TBL] [Abstract][Full Text] [Related]
9. SQSTM1/p62 and PPARGC1A/PGC-1alpha at the interface of autophagy and vascular senescence.
Salazar G; Cullen A; Huang J; Zhao Y; Serino A; Hilenski L; Patrushev N; Forouzandeh F; Hwang HS
Autophagy; 2020 Jun; 16(6):1092-1110. PubMed ID: 31441382
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway.
Zheng ZG; Zhu ST; Cheng HM; Zhang X; Cheng G; Thu PM; Wang SP; Li HJ; Ding M; Qiang L; Chen XW; Zhong Q; Li P; Xu X
Autophagy; 2021 Jul; 17(7):1592-1613. PubMed ID: 32432943
[TBL] [Abstract][Full Text] [Related]
11. Ming-Mu-Di-Huang-Pill Activates SQSTM1 via AMPK-Mediated Autophagic KEAP1 Degradation and Protects RPE Cells from Oxidative Damage.
Chen X; Zhu Y; Shi X; Zuo J; Hu T; Wu H; Xia Y; Shi W; Wei W
Oxid Med Cell Longev; 2022; 2022():5851315. PubMed ID: 35378824
[TBL] [Abstract][Full Text] [Related]
12. The SIRT2-mediated deacetylation of AKR1C1 is required for suppressing its pro-metastasis function in Non-Small Cell Lung Cancer.
Zhu H; Hu Y; Zeng C; Chang L; Ge F; Wang W; Yan F; Zhao Q; Cao J; Ying M; Gu Y; Zheng L; He Q; Yang B
Theranostics; 2020; 10(5):2188-2200. PubMed ID: 32104503
[TBL] [Abstract][Full Text] [Related]
13. Natural Product Alantolactone Targeting AKR1C1 Suppresses Cell Proliferation and Metastasis in Non-Small-Cell Lung Cancer.
Fu Z; Li S; Liu J; Zhang C; Jian C; Wang L; Zhang Y; Shi C
Front Pharmacol; 2022; 13():847906. PubMed ID: 35370661
[TBL] [Abstract][Full Text] [Related]
14. Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase.
Burczynski ME; Lin HK; Penning TM
Cancer Res; 1999 Feb; 59(3):607-14. PubMed ID: 9973208
[TBL] [Abstract][Full Text] [Related]
15. Aldo-keto reductase family 1 member C1 regulates the osteogenic differentiation of human ASCs by targeting the progesterone receptor.
Liu X; Lian X; Liu X; Du Y; Zhu Y; Hu M; Zhang P; Liu Y; Zhou Y
Stem Cell Res Ther; 2021 Jul; 12(1):383. PubMed ID: 34233738
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of SQSTM1/p62 contributes to nickel-induced malignant transformation of human bronchial epithelial cells.
Huang H; Zhu J; Li Y; Zhang L; Gu J; Xie Q; Jin H; Che X; Li J; Huang C; Chen LC; Lyu J; Gao J; Huang C
Autophagy; 2016 Oct; 12(10):1687-1703. PubMed ID: 27467530
[TBL] [Abstract][Full Text] [Related]
17. Histone H3F3/H3.3 chaperone DAXX converts to modulate SQSTM1 phase condensation for NFE2L2 activation.
Yang Y; Valionyte E; Kelly J; Luo S
Autophagy; 2020 Jan; 16(1):171-172. PubMed ID: 31607206
[TBL] [Abstract][Full Text] [Related]
18. AKR1C1 promotes non-small cell lung cancer proliferation via crosstalk between HIF-1α and metabolic reprogramming.
Chang LL; Lu PH; Yang W; Hu Y; Zheng L; Zhao Q; Lin NM; Zhang WZ
Transl Oncol; 2022 Jun; 20():101421. PubMed ID: 35429904
[TBL] [Abstract][Full Text] [Related]
19. Selective autophagy receptor SQSTM1/ p62 inhibits Seneca Valley virus replication by targeting viral VP1 and VP3.
Wen W; Li X; Yin M; Wang H; Qin L; Li H; Liu W; Zhao Z; Zhao Q; Chen H; Hu J; Qian P
Autophagy; 2021 Nov; 17(11):3763-3775. PubMed ID: 33719859
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiological roles of autophagy and aldo-keto reductases in development of doxorubicin resistance in gastrointestinal cancer cells.
Matsunaga T; Kawabata S; Yanagihara Y; Kezuka C; Kato M; Morikawa Y; Endo S; Chen H; Iguchi K; Ikari A
Chem Biol Interact; 2019 Dec; 314():108839. PubMed ID: 31563593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
